MannKind Corporation (MNKD)
NASDAQ·Healthcare·Biotechnology
$3.54
-1.12%
Mkt Cap $1.13B
Analyst Ratings
Buy
8
Hold
0
Sell
0
Price Target (12 analysts)
$8.50
Range $6.00 – $11.00
Implied Upside
+140.1%
Consensus $8.50 vs current $3.54
NASDAQ·Healthcare·Biotechnology
$3.54
-1.12%
Mkt Cap $1.13B
Buy
8
Hold
0
Sell
0
Price Target (12 analysts)
$8.50
Range $6.00 – $11.00
+140.1%
Consensus $8.50 vs current $3.54